JBS vs TSN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: JBS is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. JBS and TSN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined JBS and TSN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

JBS processes and sells animal protein at a scale nobody else matches: beef, pork, chicken and lamb, slaughtered and packed in more than a dozen countries and shipped to roughly 180. The operating structure is really six businesses under one roof. JBS Beef North America is the largest by revenue (about $7.2 billion in the first quarter of 2026), followed by Pilgrim's Pride, the US chicken company JBS controls with a stake of about ~82% and which trades separately as PPC, then JBS Brazil, Seara (branded and prepared foods in Brazil, the highest-margin unit), JBS USA Pork and JBS Australia. Brands include Friboi, Swift, Seara, Moy Park, Primo and Pilgrim's. Revenue was about $86.2 billion in 2025 and roughly ~$91 billion over the trailing twelve months, which makes JBS one of the largest food companies on earth by sales and one of the smallest by market value relative to those sales, at around ~$14 billion.

Full JBS guide

Tyson Foods, Inc. is one of the world's largest food companies and the biggest US processor of beef, pork, and chicken. As of fiscal 2026 it reports in five segments: Beef, Pork, Chicken, Prepared Foods, and International (International became a separate reportable segment in the first quarter of fiscal 2026). The Beef segment processes fed cattle into dressed carcasses and cuts; Pork fabricates market hogs into pork products; Chicken raises and processes birds into fresh, frozen, and value-added products; Prepared Foods makes branded and private-label items such as Jimmy Dean, Hillshire Farm, Ball Park, and Tyson-branded products; and International covers overseas operations. This mix means part of Tyson trades like a raw-protein commodity business and part like a branded packaged-foods company.

Full TSN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• JBS drivers: Protein and geographic diversification as a built-in hedge; A cattle cycle that mathematically has to turn.
• TSN drivers: Chicken segment strength; Prepared Foods and branded stability.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: This is a commodity processor, so margins are set by the spread between livestock costs and meat prices, and JBS controls neither. For TSN, the dominant risk is protein-commodity cyclicality, above all the cattle cycle: with cattle supply near multi-decade lows, high cattle costs are squeezing Beef margins and driving a segment operating loss that could persist until herds rebuild, a process outside Tyson's control and with no firm timeline.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick JBS if you believe its drivers more; TSN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the JBS and TSN guides.

JBS. JBS screens as one of the cheapest large food companies in the world on earnings and almost absurdly cheap on sales, but both readings need context. The trailing multiple sits on earnings that absorb a loss-making US beef unit and one-off antitrust settlements, so it is neither a peak nor a clean trough number, and the low sales ratio reflects packing economics where a 5-6% EBITDA margin is a normal outcome rather than a distressed one. The ~7.6% yield rests on a single US$1.00 payment against trailing EPS of about ~$1.07. As of mid-October 2026, 15 covering analysts carried an average twelve-month target near ~$18.52, and the November 9 third-quarter report plus the outcome of the Pilgrim's Pride proposal are the next tests.

TSN. At about $54.85 a share, Tyson trades near 34 times trailing reported EPS but only about 13 times the roughly $4.09 analysts expect for fiscal 2027, a gap that shows how charges and the Beef segment loss depress trailing earnings. The stock trades near book value (about 1.07x) and at about 0.35 times sales, typical of a low-margin protein processor in a cattle-cycle trough. Fiscal fourth-quarter results are due November 16, 2026, with consensus near $0.75 of EPS on about $14.2 billion of revenue; Walnut is not an investment adviser.

Headline figures (approximate, October 2026): JBS shows revenue (ttm) ~$91 billion, after ~$86.2 billion in FY2025 (+11.7%), q2 2026 results Record ~$24 billion net sales, ~$1.43 billion adjusted EBITDA (~6% IFRS margin), adjusted EPS ~$0.20, reported net loss ~$102 million, net income / eps (ttm) ~$1.1 billion, ~$1.07 per share, price / market cap ~$13.12 a share (October 16, 2026), ~$14 billion, 52-week range ~$10.61 to ~$18.65; TSN shows revenue (ttm) ~$55.7B, revenue growth (fiscal q3 2026, yoy) ~0% (flat), operating / net margin ~2.7% / ~1.0%, net income (ttm) ~$574M (EPS ~$1.62).

JBS and TSN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined JBS and TSN exposure against your real portfolio. It is not an investment adviser.